Essure contraceptive device to be withdrawn in the US as of 31 December 2018.-Bayer.
Bayer announced that it will no longer sell the Essure birth control device in the United States as of 31 December 2108. citing falling sales. The company asserted "inaccurate and misleading publicity about the device" that contributed to the declining interest in the product among U.S. women, as well as decreased use of permanent birth control in favor of options such as long-acting reversible contraceptives.
The FDA, in its own statement, said numerous adverse events have been associated with the Essure implant, including "a significant collection of recent reports that have mentioned issues involving surgery to remove the device."
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.